Search

Your search keyword '"Ioannidis JP"' showing total 940 results

Search Constraints

Start Over You searched for: Author "Ioannidis JP" Remove constraint Author: "Ioannidis JP"
940 results on '"Ioannidis JP"'

Search Results

53. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.

54. Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment.

57. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement.

58. New genetic loci link adipose and insulin biology to body fat distribution

59. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review

60. Noninferiority is almost certain with lenient noninferiority margins

61. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses

62. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis

63. Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines

66. Protocol for the development of a reporting guideline for umbrella reviews on epidemiological associations using cross-sectional, case-control and cohort studies: the Preferred Reporting Items for Umbrella Reviews of Cross-sectional, Case-control and Cohort studies (PRIUR-CCC).

67. Heterogeneity in elevated glucose and A1C as predictors of the prediabetes to diabetes transition: Framingham Heart Study, Multi-Ethnic Study on Atherosclerosis, Jackson Heart Study, and Atherosclerosis Risk In Communities.

68. Twelve years after the ARRIVE guidelines: Animal research has not yet arrived at high standards.

69. Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews and meta-analyses.

70. Expert Perspectives on Pilot and Feasibility Studies: A Delphi Study and Consolidation of Considerations for Behavioral Interventions.

71. Mapping and systematic appraisal of umbrella reviews in epidemiological research: a protocol for a meta-epidemiological study.

72. Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies.

73. Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study.

74. Citation impact and social media visibility of Great Barrington and John Snow signatories for COVID-19 strategy.

75. Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.

76. Overall and COVID-19-specific citation impact of highly visible COVID-19 media experts: bibliometric analysis.

77. Reporting only relative effect measures was potentially misleading: some good practices for improving the soundness of epidemiological results.

78. Large Pediatric Randomized Clinical Trials in ClinicalTrials.gov.

79. SARS-CoV-2 re-infection risk in Austria.

80. Examining the robustness of observational associations to model, measurement and sampling uncertainty with the vibration of effects framework.

82. Evaluating and Strengthening the Evidence for Nutritional Bone Research: Ready to Break New Ground?

83. Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies.

84. Systematic examination of preprint platforms for use in the medical and biomedical sciences setting.

85. Sample size evolution in neuroimaging research: An evaluation of highly-cited studies (1990-2012) and of latest practices (2017-2018) in high-impact journals.

86. Scientific petitions and open letters in the era of covid-19.

88. PROTOCOL: When and how to replicate systematic reviews.

91. A consensus-based transparency checklist.

92. Author Correction: A consensus-based transparency checklist.

93. Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard.

94. Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO).

95. Hypothesis, analysis and synthesis, it's all Greek to me.

96. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term.

97. Why Cochrane should prioritise sharing data.

98. An overview of methods for network meta-analysis using individual participant data: when do benefits arise?

99. A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

100. Enhancing the usability of systematic reviews by improving the consideration and description of interventions.

Catalog

Books, media, physical & digital resources